Glial Fibrillary Acidic Protein (GFAP) Peptide
-
- Target See all GFAP products
- GFAP (Glial Fibrillary Acidic Protein (GFAP))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- FSLAGALNAG FKETRASERA EMMELNDRFA SYIEKVRFLE QQNKALAAEL
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of GFAP antibody,
Alternative Names: GFAP control peptide, GFAP antibody Blocking Peptide, Anti-GFAP Blocking Peptide, glial fibrillary acidic protein Blocking Peptide, AI836096 Blocking Peptide
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- GFAP (Glial Fibrillary Acidic Protein (GFAP))
- Synonyms
- GFAP Peptide, AI836096 Peptide, cb345 Peptide, etID36982.3 Peptide, gfapl Peptide, wu:fb34h11 Peptide, wu:fk42c12 Peptide, xx:af506734 Peptide, zgc:110485 Peptide, glial fibrillary acidic protein Peptide, GFAP Peptide, LOC100136168 Peptide, gfap Peptide, Gfap Peptide
- Background
- GFAP, a class-III intermediate filament, is a cell-specific marker that, during the development of the central nervous system, distinguishes astrocytes from other glial cells.
- Molecular Weight
- 46 kDa
-